DETECT AF stands for DETECTion of asymptomatic Atrial Fibrillation in subjects of 65 year of age or older


Atrial fibrillation (AF) is the most common cardiac arrhythmia. Although the condition itself is not life-threatening, the complications result in increased morbidity and mortality. AF is often asymptomatic and a considerable number of people suffering from AF are not aware of their condition. Unfortunately, a cerebral infarction is often the first clinical manifestation. The idea to screen subjects opportunistically for Asymptomatic Atrial Fibrillation (AAF) was infeasible until recently. However, with a recently-developed smartphone connected Mobile ECG Device (MED), this seems to be feasible after all.

The main objectives are:

  • To examine the feasibility of screening subjects of ≥65 years old for AAF.
  • To validate the smartphone connected MED as an AAF screening instrument for application in transmural care in the Netherlands.

The DETECT AF project is a national prospective study aiming to enroll 4000 subjects in The Netherlands.

Clinical investigator

Principal investigator is Arif Elvan MD, PhD, Isala hospital Zwolle, The Netherlands.